Study Finds Bacterial Infections Linked to Coronary Heart Disease in Patients With T1D

August 12, 2020


In individuals with type 1 diabetes (T1D), bacterial infections are associated with an increased risk of coronary heart disease, according to a study published in the Journal of Internal Medicine.

Model Facilitates T1D Diagnosis in At-Risk Pediatric Populations

August 10, 2020


Researchers developed a test to better determine which children will develop type 1 diabetes (T1D), moving closer to routine testing for newborns and potentially avoiding the risk of life-threatening complications.

Study Finds Rheumatoid Arthritis Associated With Lower T2D Risk

August 05, 2020


Results from a large population-based cohort study, published in Arthritis Care & Research, found individuals with rheumatoid arthritis (RA) had a lower rate of incident type 2 diabetes (T2D) compared with the general non-RA population and cohorts with with hypertension, osteoarthritis (OA), and psoriatic arthritis (PsA).

Stress Hormone Cortisol Associated With Increased Blood Sugar in T2D Population

August 03, 2020


Throughout the country, rising cases of coronavirus disease 2019 prove stressful for individuals most at risk of dying from the disease, including those with underlying conditions such as diabetes. Compounding this issue, new results from a study published in Psychoneuroendocrinology show the stress hormone cortisol is associated with higher blood sugar levels in individuals with type 2 diabetes (T2D), suggesting cortisol plays a detrimental role in contributing to glycemia in this population.

Empagliflozin Meets Primary End Point for Heart Failure With Reduced Ejection Fraction

July 30, 2020


Results for EMPEROR-Reduced have been highly anticipated, as they are expected to set off a new round of competition in the drug class, which was first developed to treat type 2 diabetes.

Data Highlight Potential Insulin Cost Cap Savings for Pediatric T1D Population

July 30, 2020


Insulin cost-sharing caps may benefit children and young adults with type 1 diabetes (T1D), according to new research published in JAMA Pediatrics.

Study Outlines Risk of DKA in Patients Taking SGLT2 Inhibitors

July 28, 2020


Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with an almost 3-fold increased risk of diabetic ketoacidosis (DKA) in some patients with type 2 diabetes (T2D), according to data from a retrospective cohort study published in Annals of Internal Medicine.

Trump Signs 4 Executive Orders in Effort to Carry Out Promise to Lower Drug Prices

July 25, 2020


The orders President Trump signed Friday include a deadline for the pharmaceutical industry to come up with their own plan by August 24 to lower prices.

New IQVIA, JDRF Platform Will Use Real-World Data to Address T1D Diagnosis Gaps

July 24, 2020


IQVIA, a health information technology and clinical research company, recently announced a new collaboration with JDRF, the world’s largest nonprofit funder of type 1 diabetes (T1D) research. Together, the companies plan to develop a real-world research platform to facilitate evidence generation for T1D via non-identified patient-level data and analytics.

Does Gut Microbiome Composition Play a Role in T1D Pathogenesis?

July 21, 2020


Children with type 1 diabetes (T1D) have a less desirable gut microbiome composition, potentially contributing to the development of the disease, according to new research published in the Journal of Clinical Endocrinology & Metabolism.